These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38296516)

  • 21. Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic lymphadenectomy alone for endometrial cancer: Japan Clinical Oncology Group Study 1412 (SEPAL-P3).
    Watari H; Katayama H; Shibata T; Ushijima K; Satoh T; Onda T; Aoki D; Fukuda H; Yaegashi N; Sakuragi N;
    Jpn J Clin Oncol; 2017 Oct; 47(10):986-990. PubMed ID: 28981739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience.
    Volpi L; Sozzi G; Capozzi VA; Ricco' M; Merisio C; Di Serio M; Chiantera V; Berretta R
    Int J Gynecol Cancer; 2019 Feb; 29(2):312-319. PubMed ID: 30718312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6).
    Emons G; Kim JW; Weide K; de Gregorio N; Wimberger P; Trillsch F; Gabriel B; Denschlag D; Kommoss S; Aydogdu M; Papathemelis T; Gropp-Meier M; Muallem MZ; Kühn C; Müller A; Frank M; Weigel M; Bronger H; Lampe B; Rau J; Schade-Brittinger C; Harter P
    Int J Gynecol Cancer; 2021 Jul; 31(7):1075-1079. PubMed ID: 34226291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma.
    Luomaranta A; Lohi J; Bützow R; Leminen A; Loukovaara M
    Int J Gynecol Cancer; 2014 May; 24(4):697-702. PubMed ID: 24662132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes.
    Cuccu I; Raspagliesi F; Malzoni M; Vizza E; Papadia A; Di Donato V; Giannini A; De Iaco P; Perrone AM; Plotti F; Angioli R; Casarin J; Ghezzi F; Cianci S; Vizzielli G; Restaino S; Petrillo M; Sorbi F; Multinu F; Schivardi G; De Vitis LA; Falcone F; Lalli L; Berretta R; Mueller MD; Tozzi R; Chiantera V; Benedetti Panici P; Fanfani F; Scambia G; Bogani G
    Eur J Surg Oncol; 2024 Apr; 50(4):108018. PubMed ID: 38428106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
    Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E
    Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.
    Nagar H; Wietek N; Goodall RJ; Hughes W; Schmidt-Hansen M; Morrison J
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013021. PubMed ID: 34106467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphadenectomy for the management of endometrial cancer.
    May K; Bryant A; Dickinson HO; Kehoe S; Morrison J
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007585. PubMed ID: 20091639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of para-aortic lymphadenectomy in endometrial cancer.
    AlHilli MM; Mariani A
    Int J Clin Oncol; 2013 Apr; 18(2):193-9. PubMed ID: 23412768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?
    Bassarak N; Blankenstein T; Brüning A; Dian D; Bergauer F; Friese K; Mylonas I
    BMC Cancer; 2010 May; 10():224. PubMed ID: 20492712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accessory polar renal artery not pre-operatively visualized at extra-peritoneal para-aortic lymphadenectomy.
    Madsen M; Gorostidi M; Ruiz R; Jaunarena I; Cobas P; Lekuona A
    Int J Gynecol Cancer; 2019 Sep; 29(7):1226-1227. PubMed ID: 31101687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
    Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
    Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma.
    Chang SJ; Kim WY; Yoon JH; Yoo SC; Chang KH; Ryu HS
    Acta Obstet Gynecol Scand; 2008; 87(12):1361-9. PubMed ID: 18951214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
    Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
    Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors influencing the number of pelvic and para-aortic lymph nodes removed in surgical treatment of endometrial and ovarian cancer.
    Hareyama H; Ito K; Watanabe S; Hakoyama M; Uchida A; Oku K; Watanabe Y; Hayakashi Y; Hirayama E; Okuyama K
    Int J Gynecol Cancer; 2012 Nov; 22(9):1577-84. PubMed ID: 23060049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
    Venigalla S; Chowdhry AK; Shalowitz DI
    Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.